Cost-effectiveness analysis of dapagliflozin in the management of heart failure with reduced ejection fraction (HFrEF): a systematic review.

Autor: Mohammadnezhad, Ghader1 (AUTHOR), Azadmehr, Behniya1 (AUTHOR), Mirheidari, Mehdi1 (AUTHOR), Yousefi, Nazila2 (AUTHOR) n.yousefi@sbmu.ac.ir
Zdroj: Cost Effectiveness & Resource Allocation. 12/1/2022, Vol. 20 Issue 1, p1-14. 14p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje